Logo Medical XPRT
Companies
Products
Services
Software
Training
Applications
Sign in
List your business
Auro Vaccines LLC
About
  2. Companies
  3. Auro Vaccines LLC
  4. Products
  5. Auro - Model PBS VAX - ...

Auro - Model PBS VAX - Preclinical-Stage Therapeutic Vaccines for HBV

SHARE

Auro Vaccines has also developed a GeneVax prime/VesiculoVax boost therapeutic vaccine that targets all eight HBV genotypes for use as an adjunct to drug therapy.

Most popular related searches
therapeutic vaccine
vaccination
drug therapy
vaccination candidate
vaccine candidate
liver disease
drug production
vaccine targets
vaccine targeting
vaccine designed

Program Status:

Several candidate GeneVax™ prime/VesiculoVax™ vaccine combinations have been tested in small animals for immunogenicity and down-selection of the lead vaccine candidates has been completed. Further development of this candidate is currently on hold and is available for out-licensing or co-development.

Unmet Medical Need:

HBV is the most common cause of serious liver disease in the world. Worldwide over 2 billion people have been infected and 400 million remain chronically infected. More than 1 million people die each year from HBV and its complications. The Auro Vaccine GeneVax™ prime/VesiculoVax™ boost therapeutic HBV vaccine is designed to be used in conjunction with drug therapy to cure HBV infection.